| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 07/10/2013 | CN102335426B Traditional Chinese medicine animal health-care product for foot-and-mouth disease of cattle |
| 07/10/2013 | CN102335303B Chinese medicinal effective-part composition for treating cold in children and preparation method thereof |
| 07/10/2013 | CN102319439B Drug with magnetic microspheres, and use thereof |
| 07/10/2013 | CN102296078B RNA (Ribose Nucleic Acid) interference targets capable of being used for treating AIDS (Acquired Immune Deficiency Syndrome) |
| 07/10/2013 | CN102266326B Imipenem and cilastatin sodium pharmaceutical composition liposome injection |
| 07/10/2013 | CN102258776B Combined inactivated vaccine against mycoplasma hyopneumoniae (MHP) and mycoplasma hyorhinis and preparation method thereof |
| 07/10/2013 | CN102258579B Beriberi water prepared from macleaya cordata serving as raw material |
| 07/10/2013 | CN102240314B Medicine for treating urinary tract infection |
| 07/10/2013 | CN102203254B SiRNA compositions and methods for potently inhibiting viral infection |
| 07/10/2013 | CN102120030B Medicament of ilaprazole chemical structure and application thereof |
| 07/10/2013 | CN102028945B Spirulina polysaccharide immune adjuvant and influenza vaccine containing the same |
| 07/10/2013 | CN102018790B Composition for curing urinary tract infection |
| 07/10/2013 | CN102014903B 5-hydroxymethyl-oxazolidin-2-one derivatives for treating bacterial intestinal diseases |
| 07/10/2013 | CN101981038B Dioxolane and dioxolanone fused indolobenzadiazepine HCV NS5B inhibitors |
| 07/10/2013 | CN101884768B Method for preparing blood stasis-eliminating and stagnation-dissipating enema |
| 07/10/2013 | CN101821267B Compounds for the treatment of hepatitis c |
| 07/10/2013 | CN101711744B Suspension powder-injection preparation of amoxicillin sodium and flucloxacillin sodium medicinal composition and new application thereof |
| 07/10/2013 | CN101627019B Bicyclic pyrimidinones and uses thereof |
| 07/10/2013 | CN101588715B Material, item and products comprising a composition having anti-microbial properties |
| 07/10/2013 | CN101516385B Treatment of excessive neovascularization |
| 07/10/2013 | CN101463014B Diaryl benzo pyridine derivative, and its pharmaceutical composition and use thereof |
| 07/10/2013 | CN101375846B Ellagic acid supermolecule composition and preparation method |
| 07/09/2013 | US8481526 Fluoroquinolone carboxylic acid molecular crystals |
| 07/09/2013 | US8481255 Scytovirin domain 1 related polypeptides |
| 07/09/2013 | US8481091 Pharmaceutical compositions |
| 07/09/2013 | US8481056 Pro-apoptotic bacterial vaccines to enhance cellular immune responses |
| 07/09/2013 | US8481055 Method of preventing infections from bioterrorism agents with immunostimulatory CpG oligonucleotides |
| 07/09/2013 | US8481053 Compositions and methods for treating of microbial infections |
| 07/09/2013 | CA2640994C Enamel matrix protein composition for preventing or treating infection |
| 07/09/2013 | CA2640331C Stabilized pharmaceutical composition |
| 07/09/2013 | CA2588221C Modified chimeric polypeptides with improved pharmacokinetic properties |
| 07/09/2013 | CA2558600C A substituted-trialkyl amine compound with anti-viral activity based on antagonism against a chemokine receptor cxcr4 |
| 07/09/2013 | CA2506538C Bacterial superantigen vaccines |
| 07/09/2013 | CA2494216C Use of dendritic cells (dcs) expressing interleukin 12 (il-12) |
| 07/09/2013 | CA2485992C Mucosal vaccines with chitosan adjuvant and meningococcal antigens |
| 07/09/2013 | CA2463641C Antisense antiviral agent and method for treating ssrna viral infection |
| 07/09/2013 | CA2445593C Genetically modified yt cell line and use thereof |
| 07/09/2013 | CA2445565C Compositions and methods of double-targeting virus infections and cancer cells |
| 07/09/2013 | CA2430702C Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus |
| 07/09/2013 | CA2420879C Anti-microbial agents |
| 07/09/2013 | CA2408408C Modulators of tnf- alpha signaling |
| 07/04/2013 | WO2013101550A1 Solid compositions comprising an hcv inhibitor |
| 07/04/2013 | WO2013101195A1 Synthetic peptide-based marker vaccine and diagnostic system for effective control of porcine reproductive and respiratory syndrome (prrs) |
| 07/04/2013 | WO2013100721A1 Novel antibacterial and fungicidal peptide in which lysine and tryptophan residues are repeated four times, and use thereof |
| 07/04/2013 | WO2013098589A1 Adjuvanted combinations of meningococcal factor h binding proteins |
| 07/04/2013 | WO2013098320A1 Quinazolinone derivatives as hcv inhibitors |
| 07/04/2013 | WO2013098313A1 Hetero-bicyclic derivatives as hcv inhibitors |
| 07/04/2013 | WO2013098140A1 Peritoneal dialysis fluid comprising a gsk-3 inhibitor |
| 07/04/2013 | WO2013097980A1 Nifuratel sulfoxide for use in the treatment of bacterial infections |
| 07/04/2013 | WO2013097601A1 Bromodomain inhibitors |
| 07/04/2013 | WO2013064672A3 Oxazaphosphorines dosed one time for treating diseases |
| 07/04/2013 | WO2013058484A3 Ingenane-type diterpene compound, and pharmaceutical composition for treating or preventing viral infectious diseases containing same |
| 07/04/2013 | WO2013039373A3 Dialysed extract of leucocytes from shark spleen, for obtaining a transfer factor with increased potential, and method for extracting, checking and counting same |
| 07/04/2013 | WO2013019669A3 Synthetic nanocarriers that generate humoral and cytotoxic t lymphocyte (ctl) immune responses |
| 07/04/2013 | WO1999012552A8 9a-AZALIDES AS VETERINARY ANTIMICROBIAL AGENTS |
| 07/04/2013 | US20130172344 4-oxoquinoline compound and use thereof as hiv integrase inhibitor |
| 07/04/2013 | US20130172308 Antimicrobial agents |
| 07/04/2013 | US20130171191 Compositions and Methods for Enhancing Dendritic Cell Resistance to Bacterial Infection and for Enhancing the Mobility of Dendritic Cells for Dendritic Cell-Based Immunotherapy |
| 07/04/2013 | US20130171187 Glucan-based vaccines |
| 07/04/2013 | US20130171101 3-amino-2-(4-nitrophenyl)-4-(3H)-quinazolinone or derivatives thereof for treating or preventing antiviral infections |
| 07/04/2013 | US20130171074 Targeting compounds |
| 07/04/2013 | CA2857339A1 Solid compositions comprising an hcv inhibitor |
| 07/03/2013 | EP2610345A1 Recombinant influenza virus-like particles (VLPS) produced in transgenic plants expressing hemagglutinin |
| 07/03/2013 | EP2610264A2 N-[(2'r)-2'-deoxy-2'-fluoro-2'-methyl-p-phenyl-5'-uridylyl]-l-alanine 1-methylethyl ester and process for its production |
| 07/03/2013 | EP2610263A1 Sialic acid dimers |
| 07/03/2013 | EP2610253A1 Nifuratel sulfoxide for use in the treatment of bacterial infections. |
| 07/03/2013 | EP2609925A2 Dermatan sulfate for use in the treatment of pathologies wherein metalloproteinases are involved |
| 07/03/2013 | EP2609923A2 Nucleoside Phosphoramidates |
| 07/03/2013 | EP2609922A1 Pharmaceutical composition for treating chronic liver disease and use thereof |
| 07/03/2013 | EP2609918A1 Peritoneal dialysis fluid comprising a GSK-3 inhibitor |
| 07/03/2013 | EP2609917A1 Triazolyl alpha -mercaptoacetanilides as inhibitors of HIV reverse transcriptase |
| 07/03/2013 | EP2609113A1 Monoclonal antibody specific to major neutralizing epitope of influenza h5 hemagglutinin |
| 07/03/2013 | EP2609105A1 Glycodendrimers of polypropyletherimine |
| 07/03/2013 | EP2608800A2 Compositions and uses of materials with high antimicrobial activity and low toxicity |
| 07/03/2013 | EP2608776A2 Cefpodoxime proxetil formulations |
| 07/03/2013 | CN1360678B Method for early detection of flaviviruses using NS1 glycoprotein and application thereof |
| 07/03/2013 | CN103189386A Recombinant envelope protein of human immunodeficiency virus (hiv) and vaccine containing the same |
| 07/03/2013 | CN103189354A Derivatives of 1,4-dihydropyridine possessing antiviral efficacy |
| 07/03/2013 | CN103185790A High throughput screening method for anti-influenza virus inhibitor with PAC-PB1N complex as target |
| 07/03/2013 | CN103184264A HIV type I protease inhibitor screened out from crude extract of Berberis nummularia Bge, and application thereof |
| 07/03/2013 | CN103184231A Vector used for displaying antigenic epitope by using hepatitis B virus core particles, animal vaccine, and preparation method thereof |
| 07/03/2013 | CN103184230A Fusion protein gene TAT-sVP7 and application thereof |
| 07/03/2013 | CN103184224A Triple minRNA for resisting virus infection of aids and construction method thereof |
| 07/03/2013 | CN103184194A Production of avian reovirus and vaccine by using mammalian cell line |
| 07/03/2013 | CN103184171A Mycoplasma hyopneumoniae DJ-166 strain and application thereof |
| 07/03/2013 | CN103183735A Anti-HIV genetic engineering divalent antibody and preparation method thereof, and anti-HIV genetic engineering medicine |
| 07/03/2013 | CN103183728A Polypeptide used for preparing O type peptide vaccine of cattle foot-and-mouth disease and preparation methods and applications thereof |
| 07/03/2013 | CN103183726A Peptides derived from human BPLP protein, polynucleotides coding for said peptides and antibodies directed against said peptides |
| 07/03/2013 | CN103183723A 新颖的尿苷肽类抗生素及其用途 Uridine novel peptide antibiotics and their use |
| 07/03/2013 | CN103183684A Quinolone lactone compound, and preparation method and application thereof |
| 07/03/2013 | CN103183682A C-10 site carbamido substituted artemisinin derivative, preparation method and application |
| 07/03/2013 | CN103183672A Novel moxifloxacin hydrochloride crystal, and preparation method and application thereof |
| 07/03/2013 | CN103183671A Novel moxifloxacin hydrochloride crystal, and preparation method and application thereof |
| 07/03/2013 | CN103183662A Pyridine ring-containing triazole derivative and preparation method thereof |
| 07/03/2013 | CN103183631A Novel isatin-5-sulfonamide derivative and application of same in preparation of medicines used for treating atypical pneumonia |
| 07/03/2013 | CN103183625A Anti-HIV compound and preparation method and application thereof |
| 07/03/2013 | CN103183615A Extraction method of honeysuckle chlorogenic acid and its product |
| 07/03/2013 | CN103183606A 4,4'-dibasic benzophenone compound and preparation method thereof |
| 07/03/2013 | CN103183605A Preparation and application of 2-isobutoxy-5-(4-isobutoxybenzophenone)phenoxyacetic acid compound |
| 07/03/2013 | CN103182091A Polypeptide-modified drug delivery system targeting influenza virus-infected cells and preparation method and use thereof |